Human Serum Is an Advantageous Supplement for Human Dermal Fibroblast Expansion: Clinical Implications for Tissue Engineering of Skin

Archives of Medical Research

Volumn 39, Issue 8, 2008, Pages 743-752

  Mazlyzam, Abdul Latif ^a,b   Aminuddin, Bin Saim ^b,c   Saim, Lokman ^b   Ruszymah, Binti Haji Idrus ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c Ampang Puteri Specialist Hospital Malaysia   (Malaysia)

Author keywords

Cell culture; Cell cycle; Dermis; Fibroblast; Gene expression; Serum

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE S PHASE; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FETAL CALF SERUM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SKIN FIBROBLAST; SUPPLEMENTATION; TISSUE ENGINEERING;

ADULT; ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; HUMANS; SERUM; SKIN; TISSUE ENGINEERING;

EID: 55249096087     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.09.001     Document Type: Article

References (46)

1. Martin L.K., and Kirsner R.S. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol 42 (2003) 402-404
2. Llames S., Garcia E., Garcia V., del Rio M., Larcher F., Jorcano J.L., et al. Clinical results of an autologous engineered skin. Cell Tissue Bank 7 (2006) 47-53
3. Omar A.A., Mavor A.I., Jones A.M., and Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovasc Surg 27 (2004) 666-672
4. Greenberg J.E., Falabella A.F., Bello Y.M., and Schachner L.A. Tissue-engineered skin in the healing of wound stumps from limb amputations secondary to purpura fulminans. Pediatr Dermatol 20 (2003) 169-172
5. Erdag G., and Sheridan R.L. Fibroblasts improve performance of cultured composite skin substitutes on athymic mice. Burns 30 (2004) 322-328
6. Broughton II G., Janis J.E., and Attinger C.E. The basic science of wound healing. Plast Reconstr Surg 117 (2006) 12S-34S
7. Uitto J., Olsen D.R., and Fazio M.J. Extracellular matrix of the skin: 50 years of progress. J Invest Dermatol 92 (1989) 61S-77S
8. Stadelmann W.K., Digenis A.G., and Tobin G.R. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176 (1998) 26S-38S
9. Price R.D., Das-Gupta V., Harris P.A., Leigh I.M., and Navsaria H.A. The role of allogenic fibroblasts in an acute wound healing model. Plast Reconstr Surg 113 (2004) 1719-1729
10. Phan T.T., Lim I.J., Bay B.H., Qi R., Huynh H.T., Lee S.T., et al. Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J Dermatol Sci 29 (2002) 26-34
11. Mazlyzam A.L., Aminuddin B.S., Lokman B.S., Isa M.R., Fuzina H., Fauziah O., et al. Quality evaluation analysis of bioengineered human skin. Med J Malaysia 59 Suppl B (2004) 39-40
12. Liu H., Mao J., Yao K., Yang G., Cui L., and Cao Y. A study on a chitosan-gelatin-hyaluronic acid scaffold as artificial skin in vitro and its tissue engineering applications. Biomater Sci Polym J 15 (2004) 25-40
13. Llames S.G., Del Rio M., Larcher F., Garcia E., Garcia M., Escamez M.J., et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 77 (2004) 350-355
14. van der Valk J., Mellor D., Brands R., Fischer R., Gruber F., Gstraunthaler G., et al. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 18 (2004) 1-12
15. Kamil S.H., Aminuddin B.S., Bonassar L.J., Silva C.A., Weng Y., Woda M., et al. Tissue-engineered human auricular cartilage demonstrates euploidy by flow cytometry. Tissue Eng 8 (2002) 85-92
16. Johnson L.F., deSerres S., Herzog S.R., Peterson H.D., and Meyer A.A. Antigenic cross-reactivity between media supplements for cultured keratinocyte grafts. J Burn Care Rehabil 12 (1991) 306-312
17. Meyer A.A., Manktelow A., Johnson M., deSerres S., Herzog S., and Peterson H.D. Antibody response to xenogeneic proteins in burned patients receiving cultured keratinocyte grafts. J Trauma 28 (1988) 1054-1059
18. Johnson M.C., Meyer A.A., deSerres S., Herzog S., and Peterson H.D. Persistence of fetal bovine serum proteins in human keratinocytes. J Burn Care Rehabil 11 (1990) 504-509
19. Hankey D.P., McCabe R.E., Doherty M.J., Nolan P.C., McAlinden M.G., Nelson J., et al. Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum. Acta Orthop Scand 72 (2001) 395-403
20. Yamamoto N., Isobe M., Negishi A., Yoshimasu H., Shimokawa H., Ohya K., et al. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci 50 (2003) 63-69
21. Badrul A.H., Aminuddin B.S., Sharaf I., Samsudin O.C., Munirah S., and Ruszymah B.H. The effects of autologous human serum on the growth of tissue engineered human articular cartilage. Med J Malaysia 59 Suppl B (2004) 11-12
22. Azmi B., Aminuddin B.S., Sharaf I., Samsudin O.C., Munirah S., Chua K.H., et al. The significance of using pooled human serum in human articular cartilage tissue engineering. Med J Malaysia 59 Suppl B (2004) 13-14
23. Chua K.H., Aminuddin B.S., Fuzina N.H., and Ruszymah B.H. Human serum provided additional values in growth factors supplemented medium for human chondrocytes monolayer expansion and engineered cartilage construction. Med J Malaysia 59 Suppl B (2004) 194-195
24. Samsudin O.C., Aminuddin B.S., Munirah S., Chua K.H., Fuzina N.H., Isa M.R., et al. In vitro development of autologous tissue engineered human articular neocartilage for orthopaedic surgery. Med J Malaysia 59 Suppl B (2004) 15-16
25. Alexander T.H., Sage A.B., Schumacher B.L., Sah R.L., and Watson D. Human serum for tissue engineering of human nasal septal cartilage. Otolaryngol Head Neck Surg 135 (2006) 397-403
26. Chua K.H., Aminuddin B.S., Fuzina N.H., and Ruszymah B.H. Basic fibroblast growth factor with human serum supplementation: enhancement of human chondrocyte proliferation and promotion of cartilage regeneration. Singapore Med J 48 (2007) 324-332
27. Munirah S, Aminuddin B, Samsudin O, Badrul A, Azmi B, Ruszymah B. The significance of autologous human serum versus pooled human serum supplementation for human articular chondrocytes growth. J Orthopaed Surg 2008 (in press).
28. Ang L.P., Tan D.T., Seah C.J., and Beuerman R.W. The use of human serum in supporting the in vitro and in vivo proliferation of human conjunctival epithelial cells. Br J Ophthalmol 89 (2005) 748-752
29. McAlinden M.G., and Wilson D.J. Comparison of cancellous bone-derived cell proliferation in autologous human and fetal bovine serum. Cell Transplant 9 (2000) 445-451
30. Mazlyzam A.L., Aminuddin B.S., Fuzina N.H., Norhayati M.M., Fauziah O., Isa M.R., et al. Reconstruction of living bilayer human skin equivalent utilizing human fibrin as a scaffold. Burns 33 (2007) 355-363
31. Ghosh K., Ren X.D., Shu X.Z., Prestwich G.D., and Clark R.A. Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 12 (2006) 601-613
32. Desmouliere A., Chaponnier C., and Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13 (2005) 7-12
33. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12 (2001) 2730-2741
34. Wolf F., Haug M., Farhadi J., Candrian C., Martin I., and Barbero A. A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage. Eur Cell Mater 15 (2008) 1-10
35. De Castro M., Orive G., Gascon A.R., Hernandez R.M., and Pedraz J.L. Evaluation of human serum albumin as a substitute of foetal bovine serum for cell culture. Int J Pharm 310 (2006) 8-14
36. Ena J. Prions: who should worry about them?. Arch Med Res 36 (2005) 622-627
37. Products CfPM. Note for guidance on the use of bovine serum in the manufacture of human biological medical products. The European Agency for the Evaluation of Medical Products 2003; http://www.emea.eu.int/pdfs/human/bwp/179302en.pdf. Accessed 13 May 2007.
38. Coulomb B., Friteau L., Baruch J., Guilbaud J., Chretien-Marquet B., Glicenstein J., et al. Advantage of the presence of living dermal fibroblasts within in vitro reconstructed skin for grafting in humans. Plast Reconstr Surg 101 (1998) 1891-1903
39. Qian T., Hongreng Z., Zhongtao Z., Lei W., Guansen N., Ping S., et al. Culture of rat keratinocytes with acellular pig dermis. Br J Plast Surg 56 (2003) 260-265
40. Mutsaers S.E., Bishop J.E., McGrouther G., and Laurent G.J. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29 (1997) 5-17
41. Desmouliere A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122 (1993) 103-111
42. Shin D., and Minn K.W. The effect of myofibroblast on contracture of hypertrophic scar. Plast Reconstr Surg 113 (2004) 633-640
43. Harrison C.A., and MacNeil S. The mechanism of skin graft contraction: an update on current research and potential future therapies. Burns 34 (2008) 153-163
44. Riedel K., Riedel F., Goessler U.R., Germann G., and Sauerbier M. TGF-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. Arch Med Res 38 (2007) 45-51
45. Boss Jr. W.K., Usal H., Fodor P.B., and Chernoff G. Autologous cultured fibroblasts: a protein repair system. Ann Plast Surg 44 (2000) 536-542
46. Yoon E.S., Han S.K., and Kim W.K. Advantages of the presence of living dermal fibroblasts within restylane for soft tissue augmentation. Ann Plast Surg 51 (2003) 587-592